1,912
Views
48
CrossRef citations to date
0
Altmetric
Reviews

Dietary fat and gut microbiota: mechanisms involved in obesity control

, &

References

  • Abbott, S. K., P. L. Else, T. A. Atkins, and A. J. Hulbert. 2012. Fatty acid composition of membrane Bilayers: Importance of diet polyunsaturated fat balance. Biochimica et Biophysica Acta – Biomembranes 1818 (5). Elsevier B.V.: 1309–17. doi:10.1016/j.bbamem.2012.01.011.
  • Andersson, A., C. Nälsén, S. Tengblad, and B. Vessby. 2002. Fatty acid composition of skeletal muscle reflects dietary fat composition in humans. The American Journal of Clinical Nutrition 76 (6): 1222–29. doi:10.1093/ajcn/76.6.1222.
  • Angelakis, E., F. Armougom, M. Million, and D. Raoult. 2012. The relationship between gut microbiota and weight gain in humans. Future Microbiology 7 (1): 91–109. doi:10.2217/fmb.11.142.
  • Armougom, F., M. Henry, B. Vialettes, D. Raccah, and D. Raoult. 2009. Monitoring bacterial community of human gut microbiota reveals an increase in lactobacillus in obese patients and methanogens in anorexic patients. Edited by Adam J. Ratner. PLoS ONE 4 (9): e7125. doi:10.1371/journal.pone.0007125.
  • Batovska, D. I., I. T. Todorova, I.V. Tsvetkova, and H. M. Najdenski. 2009. Antibacterial study of the medium chain fatty acids and their 1-monoglycerides: individual effects and synergistic relationships. Polish Journal of Microbiology 58 (1). Elsevier Ltd: 43–47.
  • Birari, R. B., and K.K. Bhutani. 2007. Pancreatic lipase inhibitors from natural sources: Unexplored potential. Drug Discovery Today 12 (19–20): 879–89. doi:10.1016/j.drudis.2007.07.024.
  • Brahe, L. K., A. Astrup, and L. H. Larsen. 2013. Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases? Obesity Reviews 14 (12). Nature Publishing Group: 950–59. doi:10.1111/obr.12068.
  • Calder, P. C. 2011. Fatty acids and inflammation: the cutting edge between food and pharma. European Journal of Pharmacology 668 (SUPPL. 1). Elsevier B.V.: S50–58. doi:10.1016/j.ejphar.2011.05.085.
  • Cani, P. D, R. Bibiloni, C. Knauf, A. Waget, A. M Neyrinck, N. M Delzenne, and R. Burcelin. 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57 (6): 1470–81. doi:10.2337/db07-1403.
  • Chambers, E. S, A. Viardot, A. Psichas, D. J Morrison, K. G Murphy, S. E K Zac-Varghese, K. MacDougall, et al. 2015. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64 (11): 1744–54. doi:10.1136/gutjnl-2014-307913.
  • Chaplin, A., P. Parra, F. Serra, and A. Palou. 2015. Conjugated linoleic acid supplementation under a high-fat diet modulates stomach protein expression and intestinal microbiota in adult mice. Edited by Marià Alemany. PLOS ONE 10 (4): e0125091. doi:10.1371/journal.pone.0125091.
  • Chen, L., Y.-H. Zhang, T. Huang, and Y.-D. Cai. 2016. Gene expression profiling gut microbiota in different races of humans. Scientific Reports 6 (March). Nature Publishing Group: 23075. doi:10.1038/srep23075.
  • Clarke, S. F., E. F. Murphy, K. Nilaweera, P. R. Ross, F. Shanahan, P. W. O'Toole, and P. D. Cotter. 2012. The gut microbiota and its relationship to diet and obesity. Gut Microbes 3 (3): 186–202. doi:10.4161/gmic.20168.
  • Coelho, O. G. L., B. P. da Silva, D. M. U. P. Rocha, L. L. Lopes, and R. D. C. G. Alfenas. 2016. Polyunsaturated fatty acids and type 2 diabetes: Impact on the glycemic control mechanism. Critical Reviews in Food Science and Nutrition 57 (17): 3614–19. doi:10.1080/10408398.2015.1130016.
  • Cotillard, A., S. P. Kennedy, L. C. Kong, E. Prifti, N. Pons, E. L. Chatelier, M. Almeida, et al. 2013. Dietary intervention impact on gut microbial gene richness. Nature 500 (7464): 585–88. doi:10.1038/nature12480.
  • Cox, L. M., and M. J. Blaser. 2013. Pathways in microbe-induced obesity. Cell Metabolism 17 (6). Elsevier Inc.: 883–94. doi:10.1016/j.cmet.2013.05.004.
  • Dam, V., G. W. Dalmeijer, C. Vermeer, N. E. Drummen, M. H. Knapen, Y. T. V. D. Schouw, and J. W. Beulens. 2015. Association between vitamin K and the metabolic syndrome: A 10-year follow-up study in adults. The Journal of Clinical Endocrinology & Metabolism 100 (6): 2472–79. doi:10.1210/jc.2014-4449.
  • David, L. A, C. F. Maurice, R. N. Carmody, D. B. Gootenberg, J. E. Button, B. E. Wolfe, A. V. Ling, et al. 2014. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (7484). Nature Publishing Group: 559–63. doi:10.1038/nature12820.
  • Desbois, A. P., and V. J. Smith. 2010. Antibacterial free fatty acids: Activities, mechanisms of action and biotechnological potential. Applied Microbiology and Biotechnology 85 (6): 1629–42. doi:10.1007/s00253-009-2355-3.
  • Devkota, S., Y. Wang, M. W. Musch, V. Leone, H. Fehlner-Peach, A. Nadimpalli, D. Antonopoulos, B. Jabri, and E. B. Chang. 2012. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/− Mice. Nature 487 (7405): 104–108. doi:10.1038/nature11225.
  • Doré, J., and H. Blottière. 2015. The influence of diet on the gut microbiota and its consequences for health. Current Opinion in Biotechnology 32 (April): 195–99. doi:10.1016/j.copbio.2015.01.002.
  • Fava, F., R. Gitau, B. A. Griffin, G. R. Gibson, K. M. Tuohy, and J. A. Lovegrove. 2013. The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome ‘at-Risk’ population. International Journal of Obesity 37 (2). Nature Publishing Group: 216–23. doi:10.1038/ijo.2012.33.
  • Gabert, L., C. Vors, C. Louche-Pélissier, V. Sauvinet, S. Lambert-Porcheron, J. Drai, M. Laville, M. Désage, and M.-C. Michalski. 2011. 13C tracer recovery in human stools after digestion of a fat-rich meal labelled with [1,1,1-13C3]tripalmitin and [1,1,1-13C3]triolein. Rapid Communications in Mass Spectrometry 25 (19): 2697–703. doi:10.1002/rcm.5067.
  • Gao, Z., J. Yin, J. Zhang, R. E. Ward, R. J. Martin, M. Lefevre, W. T. Cefalu, and J. Ye. 2009. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58 (7): 1509–17. doi:10.2337/db08-1637.
  • Gaullier, J.-M., J. Halse, H. O. Høivik, K. Høye, C. Syvertsen, M. Nurminiemi, C. Hassfeld, A. Einerhand, M. O'Shea, and O. Gudmundsen. 2007. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. British Journal of Nutrition 97 (3): 550. doi:10.1017/S0007114507381324.
  • Ghosh, S., E. Molcan, D. DeCoffe, C. Dai, and D. L. Gibson. 2013. Diets rich in N-6 PUFA induce intestinal microbial dysbiosis in aged mice. British Journal of Nutrition 110 (3): 515–23. doi:10.1017/S0007114512005326.
  • Gomes, J. M. G., J. A. Costa, and R. C. Alfenas. 2015. Could the beneficial effects of dietary calcium on obesity and diabetes control be mediated by changes in intestinal microbiota and integrity?” British Journal of Nutrition 114 (11): 1756–65. doi:10.1017/S0007114515003608.
  • Heerklotz, H. 2008. Interactions of surfactants with lipid membranes. Quarterly Reviews of Biophysics 41 (3–4): 205. doi:10.1017/S0033583508004721.
  • Hildebrandt, M. A., C. Hoffmann, S. A. Sherrill-Mix, S. A. Keilbaugh, M. Hamady, Y.-Y. Chen, R. Knight, R. S. Ahima, F. Bushman, and G. D. Wu. 2009. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137 (5). Elsevier Inc.: 1716–24. e2. doi:10.1053/j.gastro.2009.08.042.
  • Huang, C. B., and J. L. Ebersole. 2010. A novel bioactivity of Omega-3 polyunsaturated fatty acids and their ester derivatives. Molecular Oral Microbiology 25 (1): 75–80. doi:10.1111/j.2041-1014.2009.00553.x.
  • Hullar, M. A. J., and B. C. Fu. 2014. Diet, the gut microbiome, and epigenetics. The Cancer Journal 20 (3): 170–75. doi:10.1097/PPO.0000000000000053.
  • Ichimura, A., A. Hirasawa, T. Hara, and G. Tsujimoto. 2009. Free fatty acid receptors act as nutrient sensors to regulate energy Homeostasis. Prostaglandins & Other Lipid Mediators 89 (3–4): 82–88. doi:10.1016/j.prostaglandins.2009.05.003.
  • Ierardi, E., G. Losurdo, C. Sorrentino, F. Giorgio, G. Rossi, A. Marinaro, K. R. Romagno, A. D. Leo, and M. Principi. 2016. Macronutrient intakes in obese subjects with or without small intestinal bacterial overgrowth: an alimentary survey. Scandinavian Journal of Gastroenterology 51 (3): 277–80. doi:10.3109/00365521.2015.1086020.
  • Iqbal, J., and M. M. Hussain. 2009. Intestinal lipid absorption. AJP: Endocrinology and Metabolism 296 (6). Oxford, UK: Blackwell Publishing Ltd.: E1183–94. doi:10.1152/ajpendo.90899.2008.
  • Jackman, J., B. Yoon, D. Li, and N.-J. Cho. 2016. Nanotechnology formulations for antibacterial free fatty acids and monoglycerides. Molecules 21 (3): 305. doi:10.3390/molecules21030305.
  • Kabara, J. K., D. M. Swieczkowski, A. J. Conley, and J. P. Truant. 1972. Fatty acids and derivatives as antimicrobial agents. Antimicrobial Agents and Chemotherapy 2 (1): 23–28. doi:10.1128/AAC.2.1.23.
  • Kaliannan, K., B. Wang, X.-Y. Li, K.-J. Kim, and J. X. Kang. 2015. A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia. Scientific Reports 5 (February). Nature Publishing Group: 11276. doi:10.1038/srep11276.
  • Kimura, I., K. Ozawa, D. Inoue, T. Imamura, K. Kimura, T. Maeda, K. Terasawa, et al. 2013. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nature Communications 4 (May). Nature Publishing Group: 1829. doi:10.1038/ncomms2852.
  • Koyama, I., T. Matsunaga, T. Harada, S. Hokari, and T. Komoda. 2002. Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. Clinical Biochemistry 35 (6): 455–61. doi:10.1016/S0009-9120(02)00330-2.
  • Lallès, J.-P. 2010. Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet. Nutrition Reviews 68 (6): 323–32. doi:10.1111/j.1753-4887.2010.00292.x.
  • Ley, R. E., P. J. Turnbaugh, S. Klein, and J. I. Gordon. 2006. Microbial ecology: Human gut microbes associated with obesity. Nature 444 (7122): 1022–23. doi:10.1038/4441022a.
  • Ling, L. L., T. Schneider, A. J. Peoples, A. L. Spoering, I. Engels, B. P. Conlon, A. Mueller, et al. 2015. A new antibiotic kills pathogens without detectable resistance. Nature 517 (7535): 455–59. doi:10.1038/nature14098.
  • Lucera, A., C. Costa, A. Conte, and M. A. Del Nobile. 2012. Food applications of natural antimicrobial compounds. Frontiers in Microbiology 3 (AUG): 1–13. doi:10.3389/fmicb.2012.00287.
  • Macfarlane, G. T., and S. Macfarlane. 2012. Bacteria, colonic fermentation, and gastrointestinal health. Journal of AOAC International 95 (1): 50–60. doi:10.5740/jaoacint.SGE_Macfarlane.
  • Maia, M. R. G., L. C. Chaudhary, L. Figueres, and R. J. Wallace. 2007. Metabolism of polyunsaturated fatty acids and their toxicity to the microflora of the rumen. Antonie van Leeuwenhoek 91 (4): 303–14. doi:10.1007/s10482-006-9118-2.
  • Maio, S. D, and R. L. Carrier. 2011. Gastrointestinal contents in fasted state and post-lipid ingestion: in vivo measurements and in vitro models for studying oral drug delivery. Journal of Controlled Release 151 (2). Elsevier B.V.: 110–22. doi:10.1016/j.jconrel.2010.11.034.
  • Malo, M. S., O. Moaven, N. Muhammad, B. Biswas, S. N. Alam, K. P. Economopoulos, S. S. Gul, et al. 2014. Intestinal Alkaline phosphatase promotes gut bacterial growth by reducing the concentration of luminal nucleotide triphosphates. AJP: Gastrointestinal and Liver Physiology 306 (10): G826–38. doi:10.1152/ajpgi.00357.2013.
  • Marques, T. M., R. Wall, O. O'Sullivan, G. F. Fitzgerald, F. Shanahan, E. M. Quigley, P. D. Cotter, et al. 2015. Dietary Trans-10, Cis-12-Conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice. British Journal of Nutrition 113 (5): 728–38. doi:10.1017/S0007114514004206.
  • Million, M., M. Maraninchi, M. Henry, F. Armougom, H. Richet, P. Carrieri, R. Valero, D. Raccah, B. Vialettes, and D. Raoult. 2012. Obesity-associated gut microbiota is enriched in lactobacillus reuteri and depleted in bifidobacterium animalis and methanobrevibacter smithii. International Journal of Obesity 36 (6). Nature Publishing Group: 817–25. doi:10.1038/ijo.2011.153.
  • Million, M., E. Angelakis, M. Paul, F. Armougom, L. Leibovici, and D. Raoult. 2012. Comparative meta-analysis of the effect of lactobacillus species on weight gain in humans and animals. Microbial Pathogenesis 53 (2). Elsevier Ltd: 100–108. doi:10.1016/j.micpath.2012.05.007.
  • Moreira, A. P. B., and R. D. C. G. Alfenas. 2012. The influence of endotoxemia on the molecular mechanisms of insulin resistance. Nutrición Hospitalaria 27 (2): 382–90. doi:10.1590/S0212-16112012000200007.
  • Mowat, A. M., and W. W. Agace. 2014. Regional specialization within the intestinal immune system. Nature Reviews Immunology 14 (10): 667–85. doi:10.1038/nri3738.
  • Mu, H., and C. E. Høy. 2004. The digestion of dietary triacylglycerols. Progress in Lipid Research. 43 (2): 105–33. doi:10.1016/S0163-7827(03)00050-X.
  • Mujico, J. R., G. C. Baccan, A. Gheorghe, L. E. Díaz, and A. Marcos. 2013. Changes in gut microbiota due to supplemented fatty acids in diet-induced obese mice. British Journal of Nutrition 110 (4): 711–20. doi:10.1017/S0007114512005612.
  • Murphy, E. A., K. T. Velazquez, and K. M. Herbert. 2015. Influence of high-fat diet on gut microbiota. Current Opinion in Clinical Nutrition and Metabolic Care 18 (5): 515–20. doi:10.1097/MCO.0000000000000209.
  • Murphy, E. F., P. D. Cotter, S. Healy, T. M. Marques, O. O'Sullivan, F. Fouhy, S. F. Clarke, et al. 2010. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 59 (12): 1635–42. doi:10.1136/gut.2010.215665.
  • Nakatsuji, T., M. C. Kao, J.-Y. Fang, C. C. Zouboulis, L. Zhang, R. L. Gallo, and C.-M. Huang. 2009. Antimicrobial property of lauric acid against propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. Journal of Investigative Dermatology 129 (10). Elsevier Masson SAS: 2480–88. doi:10.1038/jid.2009.93.
  • O'Flaherty, S., D. Saulnier, B. Pot, and J. Versalovic. 2010. How can probiotics and prebiotics impact mucosal immunity? Gut Microbes 1 (5): 293–300. doi:10.4161/gmic.1.5.12924.
  • Ohsaki, Y., H. Shirakawa, K. Hiwatashi, Y. Furukawa, T. Mizutani, and M. Komai. 2006. Vitamin K suppresses lipopolysaccharide-induced inflammation in the rat. Bioscience, Biotechnology and Biochemistry 70 (4): 926–32. doi:10.1271/bbb.70.926.
  • Olsen, K., K. Danielsen, T. Wilsgaard, M. Sangvik, J. U. E. Sollid, I. Thune, A. E. Eggen, G. S. Simonsen, and A. S. Furberg. 2013. Obesity and staphylococcus aureus nasal colonization among women and men in a general population. PLoS ONE 8 (5): 19–25. doi:10.1371/journal.pone.0063716.
  • Parks, B. W., E. Nam, E. Org, E. Kostem, F. Norheim, S. T. Hui, C. Pan, et al. 2013. Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metabolism 17 (1). Elsevier: 141–52. doi:10.1016/j.cmet.2012.12.007.
  • Power, S. E., P. W. O'Toole, C. Stanton, R. Paul Ross, and G. F. Fitzgerald. 2014. Intestinal microbiota, diet and health. British Journal of Nutrition 111 (3): 387–402. doi:10.1017/S0007114513002560.
  • Pusceddu, M. M., S. El Aidy, F. Crispie, O. O'Sullivan, P. Cotter, C. Stanton, P. Kelly, J. F. Cryan, and T. G. Dinan. 2015. N-3 Polyunsaturated Fatty Acids (PUFAs) reverse the impact of early-life stress on the gut microbiota. Edited by Judith Homberg. PLoS ONE 10 (10): e0139721. doi:10.1371/journal.pone.0139721.
  • Qin, J., Y. Li, Z. Cai, S. Li, J. Zhu, F. Zhang, S. Liang, et al. 2012. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490 (7418). Nature Publishing Group: 55–60. doi:10.1038/nature11450.
  • Ríos-Covián, D., P. Ruas-Madiedo, A. Margolles, M. Gueimonde, C. G. de los Reyes-Gavilán, and N. Salazar. 2016. Intestinal short chain fatty acids and their link with diet and human health. Frontiers in Microbiology 7 (February): 1–9. doi:10.3389/fmicb.2016.00185.
  • Sado-Kamdem, S. L., L. Vannini, and M. Elisabetta Guerzoni. 2009. Effect of α-linolenic, capric and lauric acid on the fatty acid biosynthesis in staphylococcus aureus. International Journal of Food Microbiology 129 (3). Elsevier B.V.: 288–94. doi:10.1016/j.ijfoodmicro.2008.12.010.
  • Sado Kamdem, S., M. E. Guerzoni, J. Baranyi, and C. Pin. 2008. Effect of capric, lauric and α-linolenic acids on the division time distributions of single cells of staphylococcus aureus. International Journal of Food Microbiology 128 (1). Elsevier B.V.: 122–28. doi:10.1016/j.ijfoodmicro.2008.08.002.
  • Salonen, A., and W. M. de Vos. 2014. Impact of diet on human intestinal microbiota and health. Annual Review of Food Science and Technology 5 (1): 239–62. doi:10.1146/annurev-food-030212-182554.
  • Sheu, C. W., and E. Freese. 1972. Effects of fatty acids on growth and envelope proteins of bacillus subtilis. Journal of Bacteriology 111 (2): 516–24. http://www.ncbi.nlm.nih.gov/pubmed/4626502.
  • Shilling, M., L. Matt, E. Rubin, M. P. Visitacion, N. A. Haller, S. F. Grey, and C. J. Woolverton. 2013. Antimicrobial effects of virgin coconut oil and its medium-chain fatty acids on clostridium difficile. Journal of Medicinal Food 16 (12): 1079–85. doi:10.1089/jmf.2012.0303.
  • Shino, B., F. C. Peedikayil, S. R. Jaiprakash, G. A. Bijapur, S. Kottayi, and D. Jose. 2016. Comparison of antimicrobial activity of chlorhexidine, coconut oil, probiotics, and ketoconazole on candida albicans isolated in children with early childhood caries: an in vitro study. Scientifica 2016: 1–5. doi:10.1155/2016/7061587.
  • Sogabe, N., R. Maruyama, O. Baba, T. Hosoi, and M. Goseki-Sone. 2011. Effects of long-term vitamin K1 (phylloquinone) or vitamin K2 (menaquinone-4) supplementation on body composition and serum parameters in rats. Bone 48 (5). Elsevier Inc.: 1036–42. doi:10.1016/j.bone.2011.01.020.
  • Swinburn, B. A., G. Sacks, K. D. Hall, K. McPherson, D. T. Finegood, M. L. Moodie, and S. L. Gortmaker. 2011. The global obesity pandemic: Shaped by global drivers and local environments. The Lancet 378 (9793). Elsevier Ltd: 804–14. doi:10.1016/S0140-6736(11)60813-1.
  • Tagliabue, A., and M. Elli. 2013. The role of gut microbiota in human obesity: Recent findings and future perspectives. Nutrition, Metabolism and Cardiovascular Diseases 23 (3). Elsevier Ltd: 160–68. doi:10.1016/j.numecd.2012.09.002.
  • Turnbaugh, P. J., F. Bäckhed, L. Fulton, and J. I. Gordon. 2008. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host & Microbe 3 (4): 213–23. doi:10.1016/j.chom.2008.02.015.
  • Turnbaugh, P. J., V. K. Ridaura, J. J. Faith, F. E. Rey, R. Knight, and J. I. Gordon. 2009. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Science Translational Medicine 1 (6): 6ra14–14. doi:10.1126/scitranslmed.3000322.
  • Verallo-Rowell, V. M., K. M. Dillague, and B. S. Syah-Tjundawan. 2008. Novel antibacterial and emollient effects of coconut and virgin olive oils in adult atopic dermatitis. Dermatitis 19 (6): 308–15.
  • Walter, J., and R. Ley. 2011. The human gut microbiome: Ecology and recent evolutionary changes. Annual Review of Microbiology 65 (1): 411–29. doi:10.1146/annurev-micro-090110-102830.
  • West, C. E., H. Renz, M. C. Jenmalm, A. L. Kozyrskyj, K. J. Allen, P. Vuillermin, and S. L. Prescott. 2015. The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies. Journal of Allergy and Clinical Immunology 135 (1): 3–13. doi:10.1016/j.jaci.2014.11.012.
  • Wu, G. D., J. Chen, C. Hoffmann, K. Bittinger, Y.-Y. Chen, S. A. Keilbaugh, M. Bewtra, et al. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (6052): 105–108. doi:10.1126/science.1208344.
  • Yang, J., and D. J Rose. 2014. Long-Term dietary pattern of fecal donor correlates with butyrate production and markers of protein fermentation during in vitro fecal fermentation. Nutrition Research 34 (9). Elsevier Inc.: 749–59. doi:10.1016/j.nutres.2014.08.006.
  • Yoon, B. K., J. A. Jackman, M. C. Kim, and N.-J. Cho. 2015. Spectrum of membrane morphological responses to antibacterial fatty acids and related surfactants. Langmuir 31 (37): 10223–32. doi:10.1021/acs.langmuir.5b02088.
  • Zhang, H., Y. Cui, S. Zhu, F. Feng, and X. Zheng. 2010. Characterization and antimicrobial activity of a pharmaceutical microemulsion. International Journal of Pharmaceutics 395 (1–2): 154–60. doi:10.1016/j.ijpharm.2010.05.022.
  • Zheng, C. J., J.-S. Yoo, T.-G. Lee, H.-Y. Cho, Y.-H. Kim, and W.-G. Kim. 2005. Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids. FEBS Letters 579 (23): 5157–62. doi:10.1016/j.febslet.2005.08.028.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.